The haemoglobin glycation index and risk for diabetes-related complications in the ADVANCE trial

被引：0
|
作者：
van Steen, S. C. J. [1 ]
Woodward, M. [2 ]
Chalmers, J. [2 ]
Li, Q. [2 ]
Marre, M. [3 ,4 ]
Cooper, M. E. [5 ]
Hamet, P. [6 ]
Mancia, G. [7 ,8 ]
Colagiuri, S. [9 ]
Williams, B. [10 ]
Grobbee, D. E. [11 ]
DeVries, J. H. [1 ]
机构：
[1] Acad Med Ctr, Endocrinol, Amsterdam, Netherlands
[2] George Inst Global Hlth, Sydney, NSW, Australia
[3] Hop Bichat Claude Bernard, Paris, France
[4] Univ Paris, Paris, France
[5] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[6] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[7] Univ Milano Bicocca, Milan, Italy
[8] Inst Auxol Italiano, Milan, Italy
[9] Boden Inst, Sydney, NSW, Australia
[10] Natl Inst Hlth Res UCL Hosp Biomed Res Ctr, London, England
[11] Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135
引用
收藏
页码：S522 / S523
页数：2
相关论文
共 50 条
  • [1] The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial
    van Steen, Sigrid C. J.
    Schrieks, Ilse C.
    Hoekstra, Joost B. L.
    Lincoff, A. Michael
    Tardif, Jean-Claude
    Mellbin, Linda G.
    Ryden, Lars
    Grobbee, Diederick E.
    DeVries, J. Hans
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (08) : 858 - 866
  • [2] Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
    Sigrid C. van Steen
    Mark Woodward
    John Chalmers
    Qiang Li
    Michel Marre
    Mark E. Cooper
    Pavel Hamet
    Giuseppe Mancia
    Stephen Colagiuri
    Bryan Williams
    Diederick E. Grobbee
    J. Hans DeVries
    [J]. Diabetologia, 2018, 61 : 780 - 789
  • [3] Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
    van Steen, Sigrid C.
    Woodward, Mark
    Chalmers, John
    Li, Qiang
    Marre, Michel
    Cooper, Mark E.
    Hamet, Pavel
    Mancia, Giuseppe
    Colagiuri, Stephen
    Williams, Bryan
    Grobbee, Diederick E.
    DeVries, J. Hans
    [J]. DIABETOLOGIA, 2018, 61 (04) : 780 - 789
  • [4] The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial
    Lachin, John M.
    Genuth, Saul
    Nathan, David M.
    Rutledge, Brandy N.
    [J]. DIABETES, 2007, 56 (07) : 1913 - 1921
  • [5] Advanced glycation endproducts in diabetes-related macrovascular complications: focus on methylglyoxal
    Schalkwijk, Casper G.
    Micali, Linda Renata
    Wouters, Kristiaan
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2023, 34 (01): : 49 - 60
  • [6] β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
    Steffes, MW
    Sibley, S
    Jackson, M
    Thomas, W
    [J]. DIABETES CARE, 2003, 26 (03) : 832 - 836
  • [7] Epidemiology of Diabetes and Diabetes-Related Complications
    Deshpande, Anjali D.
    Harris-Hayes, Marcie
    Schootman, Mario
    [J]. PHYSICAL THERAPY, 2008, 88 (11): : 1254 - 1264
  • [8] The haemoglobin glycation index is an independent risk factor for microvascular complications in UKPDS patients with newly diagnosed type 2 diabetes
    Kim, JI
    Stevens, RJ
    Holman, RR
    [J]. DIABETES, 2005, 54 : A244 - A245
  • [9] DIABETES-RELATED COMPLICATIONS OF PREGNANCY
    REECE, EA
    HOMKO, CJ
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1993, 85 (07) : 537 - 545
  • [10] Diabetes-Related Complications in Adults
    Pal, Somnath
    [J]. US PHARMACIST, 2021, 46 (11) : 14 - 14
12345